Dr. Ethan S. Lippmann is a chemical engineer and an Assistant Professor of Chemical and Biomolecular Engineering at Vanderbilt University. Dr. Lippmann’s research interests focus on applying molecular and cellular engineering techniques to model and study the blood-brain barrier (BBB) and neurovascular unit (NVU) to better understand and treat neurodegenerative diseases, such as Alzheimer’s disease. Dr. Lippmann serves as an investigator in the Vanderbilt Alzheimer’s Disease Research Center and as a preceptor for the Vanderbilt Interdisciplinary Training Program in Alzheimer’s Disease (T32).
Dr. Lippmann completed his doctoral degree in chemical engineering and a postdoctoral fellowship in biomedical engineering at University of Wisconsin-Madison. He joined the Vanderbilt faculty in 2015.